No instant look-up matches. Search within full reference content by clicking the "SEARCH" button or pressing enter.

Latest Updates in Medscape Today

View updates in other specialties
 activity indicator 
  • Bell Palsy Treatment Guidelines Are Updated Bell Palsy Treatment Guidelines Are Updated The American Academy of Neurology updated its recommendations on the use of steroids and antiviral agents for Bell Palsy treatment.
  • New Guidelines Issued for Gout Management New Guidelines Issued for Gout Management Guidelines issued by the American College of Rheumatology on the management of gout provide guidance on urate-lowering therapy, chronic tophaceous gouty arthropathy, analgesic and antiinflammatory management of acute gouty arthritis, and drug prophylaxis of acute attacks.
  • Study Clarifies Effect of Vitamin D On Upper Respiratory Tract Infection Study Clarifies Effect of Vitamin D On Upper Respiratory Tract Infection As recently reported in JAMA, oral vitamin D3 supplementation over 16 months did not reduce the number, duration or severity of URI episodes compared to placebo.
  • Guidelines Released on Diabetes Treatment Guidelines Released on Diabetes Treatment The American Diabetes Association and the European Association for the Study of Diabetes issued new recommendations on individualized treatment of type 2 diabetes.
  • Recommendations Published on Low Back Pain Management Recommendations Published on Low Back Pain Management Evidence-based guidelines published in the Journal of the American College of Radiology suggest strategies to facilitate the clinical workup and management of low back pain including recommendations on appropriate imaging, laboratory tests and referral for invasive procedures.
 

Drug Updates

  • apixaban (Eliquis) New FDA-approved Factor Xa inhibitor indicated to reduce risk of stroke and systemic embolism associated with nonvalvular atrial fibrillation
  • loxapine inhaled (Adasuve) New FDA-approved inhaled formulation of loxapine for treatment of acute agitation of schizophrenia or bipolar I disorder
  • raxibacumab New FDA-approved monoclonal antibody indicated for inhalational anthrax
  • pasireotide (Signifor) New FDA-approved somatostatin analog indicated for Cushing disease in patients for whom pituitary surgery is not an option or has not been curative
  • unoprostone ophthalmic (Rescula) Newly reintroduced prostaglandin agonist to decrease intraocular pressure in open-angle glaucoma or ocular hypertension
  • eltrombopag (Promacta) New indication for treatment of thrombocytopenia in patients with chronic hepatitis C to allow the initiation and maintenance of interferon-based therapy
  • rivaroxaban (Xarelto) New indication for treatment of DVT or PE, and for continuation therapy to reduce the risk of recurrence
  • perampanel (Fycompa) New FDA-approved AMPA receptor antagonist indicated for partial-onset seizures
  • ocriplasmin intravitreal (Jetrea) New FDA-approved proteolytic enzyme indicated for treatment of vitreomacular adhesion
  • influenza virus vaccine (Fluzone, Afluria, Fluarix, FluLaval, Fluvirin) Updated ACIP recommendations for pediatric patients requiring 2 doses of vaccine
 
 

Advisory Board

  • David Chelmow, MD, Leo J Dunn Distinguished Professor of Obstetrics and Gynecology, Virginia Commonwealth University Medical Center
  • John Geibel, MD, DSc, MA, Professor of Surgery, Yale University School of Medicine
  • Lars Grimm, MD, MHS, Duke University Medical Center
  • Jules E Harris, MD, Clinical Professor of Medicine, University of Arizona College of Medicine at Tucson
  • David J Maron, MD, FACC, FAHA, Professor of Medicine and Emergency Medicine, Vanderbilt University School of Medicine
  • Arlen D Meyers, MD, MBA, Professor of Otolaryngology and Dentistry, University of Colorado School of Medicine
  • Thomas M Wheeler, MD, Harlan J Spjut Professor of Pathology, Professor of Urology, Baylor College of Medicine
All material on this website is protected by copyright, Copyright © 1994-2013 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.